Antidepressant like effect of N(G)-Nitro-L-Arginine methyl ester

International Journal of Pharmacology

Volumn 6, Issue 3, 2010, Pages 183-191

  Chaudhari, Upama P ^a   Raje, A ^b   Trivedi, N D ^c   Bhandari, A N ^c  

^a School of Pharmacy and Technology Management   (India)

^b Wokhardt Research Center   (India)

^c Jodhpur National University   (India)

Author keywords

Antidepressant; Forced swimming test; N (G) nitro L arginine methyl ester; Nitric oxide synthase

Indexed keywords

ARGININE; CHLORPROMAZINE; CLONIDINE; CLORGYLINE; CYCLIC GMP; FLUOXETINE; GUANYLATE CYCLASE; HALOPERIDOL; IMIPRAMINE; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PINDOLOL; RESERPINE; VENLAFAXINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG HALF LIFE; ENZYME ACTIVITY; EVALUATION; FEMALE; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; SWIMMING;

EID: 77949304373     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.183.191     Document Type: Article

References (34)

1. Coskun, S., F. Karatas, F. Acarturk, H. Olmus, M. Selvi and D. Erbas, 2005. The effect of L-NAME administrations after oral mucosal incision on wound NO level m rabbit. Mol. Cell Biochem., 278: 65-69.
2. Dhir, A. and S.K. Kulkarni, 2007. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog. Neuro Psychopharmacol. Biological Psychiatry, 31: 921-925.
3. Ergun, Y. and U.G. Ergun, 2007. Prevention of pro-depressant effect of L-arginine in the forced swim test by NG-nitro-L-arginine and [1H-[1,2,4] oxadiazole [4,3-a] quinoxalin-1-one]. Eur. J. Pharmacol., 554: 150-154.
4. Eroglu, L. and B. Caglayan, 1997. Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacol. Res., 36: 381-385.
5. Esplugues, J. V., 2002. NO as a signaling molecule in the nervous system. Br. J. Pharmacol., 135: 1079-1095.
6. Filip, M. and E. Przegalinski, 1998. The role of the nitric oxide (No) pathway in the discriminative stimuli of amphetamine and cocaine. Pharmacol. Biochem. Behav., 59: 703-708.
7. Finney, D.J., 1971. Probit Analysis. 3rd Edn., Cambridge University Press, Cambridge, UK.
8. Harkin, A., T.J. Canner, N.St. John and J.P. Kelly, 2003. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitor. Neuropharmacology, 44: 616-623.
9. Harkin, A., T.J. Connor, M.P. Burns and J.P. Kelly, 2004. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol., 14: 274-281.
10. Harro, J., 2004. Animal models for better antidepressant: Can pathogenetic approaches make a difference?. Preclinica, 2: 402-407.
11. Heiberg, I.L., G. Wegener and R. Rosenberg, 2002. Reduction of cGMP and nitric oxide hasantidepressant-like effects in the forced swimming test in rats. Behav. Brain Res., 134: 479-484.
12. Janicak, P.G., 2001. Principles and Practice of Psychopharmacotherapy. 3rd Edn., Lippincott Williams and Wilkins, Philadelphia,.
13. Jefferys, D. and J. Funder, 1996. Nitric oxide modulates retention of immobility in the forced swimming test in rats. Eur. J. Pharmacol., 295: 131-135.
14. Joca, S.R. and F.S. Guimaraes, 2006. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology, 185: 298-305.
15. Kaster, M.P., P.K. Ferreira, A.R.S. Santos and A.L.S. Rodrigues, 2005. Effect of potassium channel inhibitors in the forced swimming test: Possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav. Brain Res., 165: 204-209.
16. Kulkarni, S.K. and A.K. Metha, 1985. Purine nucleoside-mediated immobility in mice: Reversal of antidepressants. Psychopharmacology, 85: 460-463.
17. Lopez, A.D. and C.J. Murray, 1996. The global burden of diseases: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. http://www.hup.harvard.edu/catalog/ MURGLO.html?show=contents.
18. Mochizucki, D., 2004. Serotonin and noradrenaline reuptake inhibitors inanimal models of pain. Hum. Psychopharmacol., 19: S15-S19.
19. Parale, M.P. and S.K. Kulkarni, 1986. Clonidine-induced behavioral despair in mice reversal by antidepressants. Psychopharmacology, 89: 171-174.
20. Patil, C.S., V.P. Singh and S.K. Kulkarni, 2005. Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil. Inflammopharmacology, 13: 467-478.
21. Porsolt, R.D., M. Le-Pichon and M. Jalfre, 1977. Depression: A new animal model sensitive to antidepressant treatments. Nature, 266: 730-732.
22. Porsolt, R.D., G. Anton, N. Blavet and M. Jalfre, 1978. Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 47: 379-391.
23. Prast, H. and A. Philippu, 2001. Nitric oxide as a modulator of neuronal function. Prog. Neurobiol., 64: 51-68.
24. Renard, C.E., E. Dailly, D.J. David M. Hascoet and M. Bourin, 2003. Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam. Clin. Pharmacol., 17: 449-455.
25. Sindrup, S.H., F.W. Bach, C. Madsen, L.F. Gram and T. S. Jensen, 2003. Venlafaxine versus imipramine in painful polyneuropathy, a randomized, controlled trial. Neurology, 60: 1284-1289.
26. Snyder, S.H. and C.D. Ferris, 2000. Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatry, 157: 1738-1751.
27. Strasser, A., R.M. McCarron, H. Ishii, D. Stanimirovic and M. Spatz, 1994. L-Arginine induces dopamine release from the striatum in vivo. Neuroreport, 5: 2298-2300.
28. Tripathi, K.D., 2004. Essentials of Medical Pharmacology. 5th Edn., Jaypee Brothers,Medical Publishers, India, pp: 890.
29. Ulak, G., O. Mutlu, F.Y. Akar, F.I. Komsouglu P. Tanyeri and B.F. Erden, 2008. Neuronal NOS inhibitor 1-(2-trifluromethylphenyl)-imidazole augments the effects of antidepressants acting via serotonergic system in the force-swimming test in rats. Pharmacol. Biochem. Behav., 90: 563-568.
30. Volke, V., G. Wegener, M. Bourin and E. Vasar, 2003. Antidepressant- and anxiolytic effects of selective neuronal NOS inhibitor 1-(2- trifluoromethylphenyl)-imidazole in mice. Behave Brain Res., 140: 141-147.
31. Wang, R., Y. Xu, H. Wu, Y. Li, Y. Li, J. Guo and X. Li, 2007. The antidepressant effects of curcumin in the forced swimming test involve 5-HT 1 an 5-HT2 receptors. Eur. J. Pharmacol., 578: 43-50.
32. Wegener, G., V. Volke, B.H. Harvey and R. Rosenberg, 2003. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res., 959: 128-134.
33. Yildiz, F., B.F. Erden, G. Ulak, T. Utkan and N. Gacar, 2000. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology, 149: 41-44.
34. Zhu, X.Z. and L.G. Luo, 1992. Effect of nitroprusside nitric oxide on endogenous dopamine release from rat striatal slices. J. Neurochemistry, 59: 932-935.